The Suture Size in Laparotomy Wound Closure to Prevent Post-operative Complications
NCT ID: NCT05474677
Last Updated: 2022-08-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
276 participants
INTERVENTIONAL
2022-08-01
2025-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Objective: Identify the best suture size for closure of the fascia following laparotomy incisions, by assessing the suture size 2\\0 versus zero.
Research methods: Prospective, multicentric, randomized controlled and double-blind trial. Patients undergoing elective or emergency laparotomy in Royal Hospital, Sultan Qaboos University Hospital and Armed Force Hospital between 2022 and 2023. We aimed for a total of 276 patients (n=138 per group). The abdomen will be closed in intervention group with continuous PDS 2\\0 sutures and size zero in control group. Patients will be followed for immediate post-operative wound complications and late complication after 6 months then after one year.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Small-bite Versus Conventional Midline Fascial Closure in Abdominal Surgeries
NCT07340918
Small Bite Technique Versus Standardised Large Bites Technique in Closure of Midline Laparotomies.
NCT04788875
Clinical Performance and Safety of Suture-TOOL
NCT05695157
Effect of Continuous Versus Interrupted Suturing on Wound Dehiscence and Infection After Abdominal Surgery
NCT07241507
Comparing Wound Complications After Elective Abdominal Surgery Using Two Closure Techniques
NCT03527433
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Secondary objective: assess the incidence of wound dehiscence and wound infection in two studied group.
Study hypothesis: Suture size 2/0 decreases the incidence of incisional hernia in the closure of the abdominal fascia
Research design and Methods Study design: Prospective, multicentric, randomized controlled and double-blind trial.
Characteristics of study area and target population Patients undergoing elective or emergency laparotomy in Royal Hospital, Sultan Qaboos University Hospital and Armed Force Hospital between 2022 and 2023. Eligible patients are adults aged 18 years or older, who signed informed consent and the expected survival more than one year. Patients with history of midline laparotomy within 3 months, pregnant patients and patients with history of incisional hernia will be excluded from the study.
Sampling we estimated that 125 patients would be needed in each group to provide 80% power to detect a reduction of at least 50% (18% in the classic group vs 6% in the 2.0 group) in the incidence of incisional hernia at a two-sided alpha level 0.05. We aimed for a total of 276 patients (n=138 per group) to correct for an estimated 10% loss to follow-up in each group. The statistical method used was Fisher's exact test. The calculation was done using the software G\*Power version 3.1.9.2. Randomization will be achieved by using a software.
Variable definitions and measurements The abdomen will be closed in the intervention group patients with continuous PDS 2\\0 sutures, half centimeter between each stitch. The control group will be closed by the conventional method in the Royal Hospital, continuous using double-looped. Sex, age, BMI, smoking, diabetes mellitus, COPD, cardiovascular disease, corticosteroid use, previous laparotomy, ASA classification, preoperative chemotherapy, preoperative radiotherapy, type of surgery are the variable which will be studied.
Data collection tools and methods Data will be entered using Epi-data software.
Data quality State how data will be entered using Epi-data software.
Data analysis Continuous variables will be presented as mean, median, and standard deviation whereas, categorical variables will be presented as frequency and percentage. Comparison of means between two groups will be assessed using the independent samples t-test or the Mann-Whitney U test, as appropriate. Association between two categorical variables will be assessed using an appropriate Chi-square test (Likelihood ratio test or Fisher's exact test). Multivariate log-binomial regression analysis will be used to determine the independent risk factors for the development of incisional hernia. A P-value less than 0.05 will be considered statistically significant. All the analysis will be done using the IBM SPSS statistics version 26.0.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
intervention group
intervention group with the abdomen will be closed with continuous PDS 2\\0 sutures
closure of the abdominal fascia
The abdomen will be closed in intervention group with continuous PDS 2\\0 sutures and size zero in control group.
control group
the abdomen will be closed with continuous sutures size zero
closure of the abdominal fascia
The abdomen will be closed in intervention group with continuous PDS 2\\0 sutures and size zero in control group.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
closure of the abdominal fascia
The abdomen will be closed in intervention group with continuous PDS 2\\0 sutures and size zero in control group.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Raya Al shaaibi
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Raya Al shaaibi
Dr
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
mohmmed al abri, consultant
Role: STUDY_DIRECTOR
Oman Medical Specialty Board
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Raya Al Shaaibi
Muscat, , Oman
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
OmanMedSB
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.